Global Human Microbiome Market Size, Share, and COVID-19 Impact Analysis, By Product (Drugs, Probiotics, Prebiotics, and Synbiotics), By Disease (Infectious, Gastrointestinal, and Endocrine & Metabolic), By Type (BCT/FMT and Live Biotherapeutics), By End User (Hospitals & Clinics and Long-term Care), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035
Industry: Healthcare- Introduction
- Objectives of the Study
- Market Definition
- Research Scope
- Research Methodology and Assumptions
- Executive Summary
- Premium Insights
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Top Investment Pockets
- Market Attractiveness Analysis By Product
- Market Attractiveness Analysis By Disease
- Market Attractiveness Analysis By Type
- Market Attractiveness Analysis By End User
- Market Attractiveness Analysis By Region
- Industry Trends
- Market Dynamics
- Market Evaluation
- Drivers
- Significance of the microbiome’s role in health and disease
- Surging trend of personalized medicine
- Restraints
- Lack of awareness and education among patients and healthcare providers
- Opportunities
- Revolutionization of microbiome-based therapies by the use of AI-driven technologies
- Challenges
- Complex regulatory policies and increased investment required for the commercialization of human microbiome products
- Global Human Microbiome Market Analysis and Projection, By Product
- Segment Overview
- Drugs
- Probiotics
- Prebiotics
- Synbiotics
- Global Human Microbiome Market Analysis and Projection, By Disease
- Segment Overview
- Infectious
- Gastrointestinal
- Endocrine & Metabolic
- <<Sub2_se4>>
- Global Human Microbiome Market Analysis and Projection, By Type
- Segment Overview
- BCT/FMT
- Live Biotherapeutics
- Global Human Microbiome Market Analysis and Projection, By End User
- Segment Overview
- Hospitals & Clinics
- Long-term Care
- Global Human Microbiome Market Analysis and Projection, By Regional Analysis
- Segment Overview
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Asia-Pacific
- Japan
- China
- India
- South America
- Brazil
- Middle East and Africa
- UAE
- South Africa
- Global Human Microbiome Market-Competitive Landscape
- Overview
- Market Share of Key Players in the Human Microbiome Market
- Global Company Market Share
- North America Company Market Share
- Europe Company Market Share
- APAC Company Market Share
- Competitive Situations and Trends
- Coverage Launches and Developments
- Partnerships, Collaborations, and Agreements
- Mergers & Acquisitions
- Expansions
- Company Profiles
- Seres Therapeutics
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- BiomeBank
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- BioHM Health Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Optibiotix Health plc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Infinant Health Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Exegi Pharma LLC
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Ferring Pharmaceuticals
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Seed Health, Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Pendulum
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Actial Farmaceutica SRL
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Resbiotic
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Biogaia AB
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Vedanta Biosciences Inc.
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Others
- Business Overview
- Company Snapshot
- Company Market Share Analysis
- Company Coverage Portfolio
- Recent Developments
- SWOT Analysis
- Seres Therapeutics
List of Table
- Global Human Microbiome Market, By Product, 2024-2035(USD Billion)
- Global Drugs, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- Global Probiotics, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- Global Prebiotics, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- Global Synbiotics, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- Global Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- Global Infectious, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- Global Gastrointestinal, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- Global Endocrine & Metabolic, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- Global Human Microbiome Market, By Type, 2024-2035(USD Billion)
- Global BCT/FMT, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- Global Live Biotherapeutics, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- Global Human Microbiome Market, By End User, 2024-2035(USD Billion)
- Global Hospitals & Clinics, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- Global Long-term Care, Human Microbiome Market, By Region, 2024-2035(USD Billion)
- North America Human Microbiome Market, By Product, 2024-2035(USD Billion)
- North America Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- North America Human Microbiome Market, By Type, 2024-2035(USD Billion)
- North America Human Microbiome Market, By End User, 2024-2035(USD Billion)
- North America Human Microbiome Market, By <<Seg5>>, 2024-2035(USD Billion)
- U.S. Human Microbiome Market, By Product, 2024-2035(USD Billion)
- U.S. Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- U.S. Human Microbiome Market, By Type, 2024-2035(USD Billion)
- U.S. Human Microbiome Market, By End User, 2024-2035(USD Billion)
- Canada Human Microbiome Market, By Product, 2024-2035(USD Billion)
- Canada Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- Canada Human Microbiome Market, By Type, 2024-2035(USD Billion)
- Canada Human Microbiome Market, By End User, 2024-2035(USD Billion)
- Mexico Human Microbiome Market, By Product, 2024-2035(USD Billion)
- Mexico Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- Mexico Human Microbiome Market, By Type, 2024-2035(USD Billion)
- Mexico Human Microbiome Market, By End User, 2024-2035(USD Billion)
- Europe Human Microbiome Market, By Product, 2024-2035(USD Billion)
- Europe Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- Europe Human Microbiome Market, By Type, 2024-2035(USD Billion)
- Europe Human Microbiome Market, By End User, 2024-2035(USD Billion)
- Germany Human Microbiome Market, By Product, 2024-2035(USD Billion)
- Germany Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- Germany Human Microbiome Market, By Type, 2024-2035(USD Billion)
- Germany Human Microbiome Market, By End User, 2024-2035(USD Billion)
- France Human Microbiome Market, By Product, 2024-2035(USD Billion)
- France Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- France Human Microbiome Market, By Type, 2024-2035(USD Billion)
- France Human Microbiome Market, By End User, 2024-2035(USD Billion)
- U.K. Human Microbiome Market, By Product, 2024-2035(USD Billion)
- U.K. Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- U.K. Human Microbiome Market, By Type, 2024-2035(USD Billion)
- U.K. Human Microbiome Market, By End User, 2024-2035(USD Billion)
- Italy Human Microbiome Market, By Product, 2024-2035(USD Billion)
- Italy Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- Italy Human Microbiome Market, By Type, 2024-2035(USD Billion)
- Italy Human Microbiome Market, By End User, 2024-2035(USD Billion)
- Spain Human Microbiome Market, By Product, 2024-2035(USD Billion)
- Spain Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- Spain Human Microbiome Market, By Type, 2024-2035(USD Billion)
- Spain Human Microbiome Market, By End User, 2024-2035(USD Billion)
- Asia Pacific Human Microbiome Market, By Product, 2024-2035(USD Billion)
- Asia Pacific Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- Asia Pacific Human Microbiome Market, By Type, 2024-2035(USD Billion)
- Asia Pacific Human Microbiome Market, By End User, 2024-2035(USD Billion)
- Japan Human Microbiome Market, By Product, 2024-2035(USD Billion)
- Japan Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- Japan Human Microbiome Market, By Type, 2024-2035(USD Billion)
- Japan Human Microbiome Market, By End User, 2024-2035(USD Billion)
- China Human Microbiome Market, By Product, 2024-2035(USD Billion)
- China Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- China Human Microbiome Market, By Type, 2024-2035(USD Billion)
- China Human Microbiome Market, By End User, 2024-2035(USD Billion)
- India Human Microbiome Market, By Product, 2024-2035(USD Billion)
- India Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- India Human Microbiome Market, By Type, 2024-2035(USD Billion)
- India Human Microbiome Market, By End User, 2024-2035(USD Billion)
- South America Human Microbiome Market, By Product, 2024-2035(USD Billion)
- South America Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- South America Human Microbiome Market, By Type, 2024-2035(USD Billion)
- South America Human Microbiome Market, By End User, 2024-2035(USD Billion)
- Brazil Human Microbiome Market, By Product, 2024-2035(USD Billion)
- Brazil Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- Brazil Human Microbiome Market, By Type, 2024-2035(USD Billion)
- Brazil Human Microbiome Market, By End User, 2024-2035(USD Billion)
- The Middle East and Africa Human Microbiome Market, By Product, 2024-2035(USD Billion)
- The Middle East and Africa Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- The Middle East and Africa Human Microbiome Market, By Type, 2024-2035(USD Billion)
- The Middle East and Africa Human Microbiome Market, By End User, 2024-2035(USD Billion)
- UAE Human Microbiome Market, By Product, 2024-2035(USD Billion)
- UAE Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- UAE Human Microbiome Market, By Type, 2024-2035(USD Billion)
- UAE Human Microbiome Market, By End User, 2024-2035(USD Billion)
- South Africa Human Microbiome Market, By Product, 2024-2035(USD Billion)
- South Africa Human Microbiome Market, By Disease, 2024-2035(USD Billion)
- South Africa Human Microbiome Market, By Type, 2024-2035(USD Billion)
- South Africa Human Microbiome Market, By End User, 2024-2035(USD Billion)
List of Figures
- Global Human Microbiome Market Segmentation
- Human Microbiome Market: Research Methodology
- Market Size Estimation Methodology: Bottom-Up Approach
- Market Size Estimation Methodology: Top-down Approach
- Data Triangulation
- Porter’s Five Forces Analysis
- Value Chain Analysis
- Top investment pocket in the Human Microbiome Market
- Top Winning Strategies, 2024-2035
- Top Winning Strategies, By Development, 2024-2035(%)
- Top Winning Strategies, By Company, 2024-2035
- Moderate Bargaining power of Buyers
- Moderate Bargaining power of Suppliers
- Moderate Bargaining power of New Entrants
- Low threat of Substitution
- High Competitive Rivalry
- Top Player Positioning, 2024
- Market Share Analysis, 2024
- Restraint and Drivers: Human Microbiome Market
- Human Microbiome Market Segmentation, By Product
- Human Microbiome Market For Drugs, By Region, 2024-2035 ($ Billion)
- Human Microbiome Market For Probiotics, By Region, 2024-2035 ($ Billion)
- Human Microbiome Market For Prebiotics, By Region, 2024-2035 ($ Billion)
- Human Microbiome Market For Synbiotics, By Region, 2024-2035 ($ Billion)
- Human Microbiome Market Segmentation, By Disease
- Human Microbiome Market For Infectious, By Region, 2024-2035 ($ Billion)
- Human Microbiome Market For Gastrointestinal, By Region, 2024-2035 ($ Billion)
- Human Microbiome Market For Endocrine & Metabolic, By Region, 2024-2035 ($ Billion)
- Human Microbiome Market Segmentation, By Type
- Human Microbiome Market For BCT/FMT, By Region, 2024-2035 ($ Billion)
- Human Microbiome Market For Live Biotherapeutics, By Region, 2024-2035 ($ Billion)
- Human Microbiome Market Segmentation, By End User
- Human Microbiome Market For Hospitals & Clinics, By Region, 2024-2035 ($ Billion)
- Human Microbiome Market For Long-term Care, By Region, 2024-2035 ($ Billion)
- Seres Therapeutics: Net Sales, 2024-2035 ($ Billion)
- Seres Therapeutics: Revenue Share, By Segment, 2024 (%)
- Seres Therapeutics: Revenue Share, By Region, 2024 (%)
- BiomeBank: Net Sales, 2024-2035 ($ Billion)
- BiomeBank: Revenue Share, By Segment, 2024 (%)
- BiomeBank: Revenue Share, By Region, 2024 (%)
- BioHM Health Inc.: Net Sales, 2024-2035 ($ Billion)
- BioHM Health Inc.: Revenue Share, By Segment, 2024 (%)
- BioHM Health Inc.: Revenue Share, By Region, 2024 (%)
- Optibiotix Health plc.: Net Sales, 2024-2035 ($ Billion)
- Optibiotix Health plc.: Revenue Share, By Segment, 2024 (%)
- Optibiotix Health plc.: Revenue Share, By Region, 2024 (%)
- Infinant Health Inc.: Net Sales, 2024-2035 ($ Billion)
- Infinant Health Inc.: Revenue Share, By Segment, 2024 (%)
- Infinant Health Inc.: Revenue Share, By Region, 2024 (%)
- Exegi Pharma LLC: Net Sales, 2024-2035 ($ Billion)
- Exegi Pharma LLC: Revenue Share, By Segment, 2024 (%)
- Exegi Pharma LLC: Revenue Share, By Region, 2024 (%)
- Ferring Pharmaceuticals: Net Sales, 2024-2035 ($ Billion)
- Ferring Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
- Ferring Pharmaceuticals: Revenue Share, By Region, 2024 (%)
- Seed Health, Inc.: Net Sales, 2024-2035 ($ Billion)
- Seed Health, Inc.: Revenue Share, By Segment, 2024 (%)
- Seed Health, Inc.: Revenue Share, By Region, 2024 (%)
- Pendulum.: Net Sales, 2024-2035 ($ Billion)
- Pendulum.: Revenue Share, By Segment, 2024 (%)
- Pendulum.: Revenue Share, By Region, 2024 (%)
- Actial Farmaceutica SRL: Net Sales, 2024-2035 ($ Billion)
- Actial Farmaceutica SRL: Revenue Share, By Segment, 2024 (%)
- Actial Farmaceutica SRL: Revenue Share, By Region, 2024 (%)
- Resbiotic: Net Sales, 2024-2035 ($ Billion)
- Resbiotic: Revenue Share, By Segment, 2024 (%)
- Resbiotic: Revenue Share, By Region, 2024 (%)
- Biogaia AB: Net Sales, 2024-2035 ($ Billion)
- Biogaia AB: Revenue Share, By Segment, 2024 (%)
- Biogaia AB: Revenue Share, By Region, 2024 (%)
- Vedanta Biosciences Inc.: Net Sales, 2024-2035 ($ Billion)
- Vedanta Biosciences Inc.: Revenue Share, By Segment, 2024 (%)
- Vedanta Biosciences Inc.: Revenue Share, By Region, 2024 (%)
- Others: Net Sales, 2024-2035 ($ Billion)
- Others: Revenue Share, By Segment, 2024 (%)
- Others: Revenue Share, By Region, 2024 (%)
Need help to buy this report?
Inquiry Before Buy